v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Total Shareholders’ Equity Attributable to The Vita Coco Company, Inc.
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income / (Loss)
Treasury Stock
Common Stock
Common Stock
Common Stock with Exit Warrants
Common Stock
Beginning balance, common stock (in shares) at Dec. 31, 2024     63,702,387         55,589,282 8,113,105
Beginning balance at Dec. 31, 2024   $ 258,817 $ 637 $ 174,077 $ 156,694 $ (860) $ (71,731) $ 556 $ 81
Beginning balance, treasury stock (in shares) at Dec. 31, 2024             6,740,446    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to The Vita Coco Company, Inc.   18,882     18,882        
Purchase of treasury stock (in shares)             48,973    
Purchase of treasury stock   (1,501)         $ (1,501)    
Stock-based compensation   2,186   2,186          
Exercised (in shares)     105,332         105,332  
Exercise of stock awards   (1,021) $ 1 (1,022)       $ 1  
Foreign currency translation adjustment   495       495      
Ending balance, common stock (in shares) at Mar. 31, 2025     63,807,719         55,694,614 8,113,105
Ending balance at Mar. 31, 2025   277,858 $ 638 175,241 175,576 (365) $ (73,232) $ 557 $ 81
Ending balance, treasury stock (in shares) at Mar. 31, 2025             6,789,419    
Beginning balance, common stock (in shares) at Dec. 31, 2024     63,702,387         55,589,282 8,113,105
Beginning balance at Dec. 31, 2024   258,817 $ 637 174,077 156,694 (860) $ (71,731) $ 556 $ 81
Beginning balance, treasury stock (in shares) at Dec. 31, 2024             6,740,446    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to The Vita Coco Company, Inc. $ 65,793                
Foreign currency translation adjustment 1,409                
Ending balance, common stock (in shares) at Sep. 30, 2025     64,027,120         55,914,015 8,113,105
Ending balance at Sep. 30, 2025   323,733 $ 640 181,992 222,487 549 $ (81,935) $ 559 $ 81
Ending balance, treasury stock (in shares) at Sep. 30, 2025             7,078,862    
Beginning balance, common stock (in shares) at Dec. 31, 2024     63,702,387         55,589,282 8,113,105
Beginning balance at Dec. 31, 2024   258,817 $ 637 174,077 156,694 (860) $ (71,731) $ 556 $ 81
Beginning balance, treasury stock (in shares) at Dec. 31, 2024             6,740,446    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Purchase of treasury stock (in shares)     363,930            
Purchase of treasury stock $ (11,269)                
Ending balance, common stock (in shares) at Dec. 31, 2025 57,082,173   64,186,549         56,073,444 8,113,105
Ending balance at Dec. 31, 2025 $ 331,542 331,542 $ 642 185,400 228,014 486 $ (83,000) $ 561 $ 81
Ending balance, treasury stock (in shares) at Dec. 31, 2025 7,104,376           7,104,376    
Beginning balance, common stock (in shares) at Mar. 31, 2025     63,807,719         55,694,614 8,113,105
Beginning balance at Mar. 31, 2025   277,858 $ 638 175,241 175,576 (365) $ (73,232) $ 557 $ 81
Beginning balance, treasury stock (in shares) at Mar. 31, 2025             6,789,419    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to The Vita Coco Company, Inc.   22,908     22,908        
Purchase of treasury stock (in shares)             284,728    
Purchase of treasury stock   (8,552)         $ (8,552)    
Stock-based compensation   2,962   2,962          
Exercised (in shares)     69,409         69,409  
Exercise of stock awards   572 $ 1 571       $ 1  
Foreign currency translation adjustment   1,191       1,191      
Ending balance, common stock (in shares) at Jun. 30, 2025     63,877,128         55,764,023 8,113,105
Ending balance at Jun. 30, 2025   296,939 $ 639 178,774 198,484 826 $ (81,784) $ 558 $ 81
Ending balance, treasury stock (in shares) at Jun. 30, 2025             7,074,147    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to The Vita Coco Company, Inc. $ 24,003 24,003     24,003        
Purchase of treasury stock (in shares)             4,715    
Purchase of treasury stock   (151)         $ (151)    
Stock-based compensation   2,975   2,975          
Exercised (in shares)     149,992         149,992  
Exercise of stock awards   244 $ 1 243       $ 1  
Foreign currency translation adjustment $ (277) (277)       (277)      
Ending balance, common stock (in shares) at Sep. 30, 2025     64,027,120         55,914,015 8,113,105
Ending balance at Sep. 30, 2025   323,733 $ 640 181,992 222,487 549 $ (81,935) $ 559 $ 81
Ending balance, treasury stock (in shares) at Sep. 30, 2025             7,078,862    
Beginning balance, common stock (in shares) at Dec. 31, 2025 57,082,173   64,186,549         56,073,444 8,113,105
Beginning balance at Dec. 31, 2025 $ 331,542 331,542 $ 642 185,400 228,014 486 $ (83,000) $ 561 $ 81
Beginning balance, treasury stock (in shares) at Dec. 31, 2025 7,104,376           7,104,376    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to The Vita Coco Company, Inc.   30,474     30,474        
Purchase of treasury stock (in shares)             225,273    
Purchase of treasury stock   (11,505)         $ (11,505)    
Stock-based compensation   4,626   4,626          
Exercised (in shares)     249,405         249,405  
Exercise of stock awards   (2,504) $ 2 (2,506)       $ 2  
Foreign currency translation adjustment   (460)       (460)      
Ending balance, common stock (in shares) at Mar. 31, 2026     64,435,954         56,322,849 8,113,105
Ending balance at Mar. 31, 2026   352,173 $ 644 187,520 258,488 26 $ (94,505) $ 563 $ 81
Ending balance, treasury stock (in shares) at Mar. 31, 2026             7,329,649    
Beginning balance, common stock (in shares) at Dec. 31, 2025 57,082,173   64,186,549         56,073,444 8,113,105
Beginning balance at Dec. 31, 2025 $ 331,542 331,542 $ 642 185,400 228,014 486 $ (83,000) $ 561 $ 81
Beginning balance, treasury stock (in shares) at Dec. 31, 2025 7,104,376           7,104,376    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to The Vita Coco Company, Inc. $ 114,942                
Purchase of treasury stock (in shares)     1,089,521            
Purchase of treasury stock (62,410)                
Foreign currency translation adjustment $ (1,536)                
Ending balance, common stock (in shares) at Sep. 30, 2026 57,202,356   65,396,253         57,283,148 8,113,105
Ending balance at Sep. 30, 2026 $ 428,728 428,728 $ 654 231,578 342,956 (1,050) $ (145,410) $ 573 $ 81
Ending balance, treasury stock (in shares) at Sep. 30, 2026 8,193,897           8,193,897    
Beginning balance, common stock (in shares) at Mar. 31, 2026     64,435,954         56,322,849 8,113,105
Beginning balance at Mar. 31, 2026   352,173 $ 644 187,520 258,488 26 $ (94,505) $ 563 $ 81
Beginning balance, treasury stock (in shares) at Mar. 31, 2026             7,329,649    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to The Vita Coco Company, Inc.   49,451     49,451        
Purchase of treasury stock (in shares)             173,618    
Purchase of treasury stock   (8,503)         $ (8,503)    
Stock-based compensation   3,590   3,590          
Exercised (in shares)     464,395         464,395  
Exercise of stock awards   4,506 $ 5 4,501       $ 5  
Foreign currency translation adjustment   (313)       (313)      
Ending balance, common stock (in shares) at Jun. 30, 2026     64,900,349         56,787,244 8,113,105
Ending balance at Jun. 30, 2026   400,904 $ 649 195,611 307,939 (287) $ (103,008) $ 568 $ 81
Ending balance, treasury stock (in shares) at Jun. 30, 2026             7,503,267    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to The Vita Coco Company, Inc. $ 35,017 35,017     35,017        
Purchase of treasury stock (in shares)     690,630       690,630    
Purchase of treasury stock (42,402) (42,402)         $ (42,402)    
Stock Issued During Period, Value, Acquisitions   35,000 $ 5 34,995       $ 5  
Business combination, consideration transferred, equity interest, share issued, number of shares     467,071         467,071  
Stock-based compensation   3,122   3,122          
Exercised (in shares)     28,833         28,833  
Exercise of stock awards   (2,150)   (2,150)          
Foreign currency translation adjustment $ (763) (763)       (763)      
Ending balance, common stock (in shares) at Sep. 30, 2026 57,202,356   65,396,253         57,283,148 8,113,105
Ending balance at Sep. 30, 2026 $ 428,728 $ 428,728 $ 654 $ 231,578 $ 342,956 $ (1,050) $ (145,410) $ 573 $ 81
Ending balance, treasury stock (in shares) at Sep. 30, 2026 8,193,897           8,193,897